1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > CNS Drug News 16 FEBRUARY 2015

CNS Drug News 16 FEBRUARY 2015

  • February 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Abuse-Deterrent Opioid Market Seeing High Activity
Industry Trend Analysis - Neupro's Expansion Into China Will Boost UCB's Revenues
Industry Brief - Teva UK Launches Memantine
Industry Brief - AB Science Reports Successful Completion Of Futility Test For Masitinib In AD
Industry Brief - Regulus Earns Milestone From Biogen Idec In MS Biomarker Collaboration
Industry Brief - Isis Earns Milestone From Biogen Idec For Advancing New Drug Into Development
Industry Brief - FORUM Initiates Phase IIa Trial Of FRM-0334 In FTD-GRN
Industry Trend Analysis - Merck's New Insomnia Medicine Has Limited Commercial Potential
Industry Brief - VistaGen/NIH Sign CRADA For AV-101 Phase II Study In MDD
Industry Brief - Actavis Launches Aripiprazole In UK
Industry Brief - FDA Accepts NDA For IDT's Abuse-Deterrent MorphaBond ER
Industry Brief - FDA Accepts For Filing Collegium's NDA For Abuse-Deterrent Xtampza ER
Industry Brief - Orexo Files Fentanyl Patent Litigation Against Actavis
Industry Brief - Enrolment Begins In Daiichi Sankyo's Mirogabalin Phase III Programmes
Industry Brief - Orexo Broadens Zubsolv Product Range; New US Patent Issued
Industry Brief - FDA Grants Fast Track Designation For Intranasal Naloxone To Reverse Opioid Overdose
Industry Brief - FDA Approves sNDA For Eisai's Banzel
Industry Brief - Milestone Triggered As Belviq Approved In South Korea For Weight Management
Industry Brief - Helsinn Signs Exclusive Agreement With Mundipharma For NEPA In Brazil
Industry Trend Analysis - Genzyme/Voyager Deal Demonstrates Gene Therapy's Revival
Industry Trend Analysis - J&J Guiding Drug Development With New Research Platforms
Industry Trend Analysis - In Vitro Diagnostics Impacting Pharmaceutical R&D
Industry Brief - AstraZeneca Gains Planning Consent For Global R&D Centre/Corporate HQ In Cambridge
Industry Brief - The Medicines Company Acquires Annovation Biopharma

Table Of Contents

CNS Drug News 16 FEBRUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


Download Unlimited Documents from Trusted Public Sources

Anti-Infective Market in Tanzania

  • December 2016
    9 pages
  • Anti-Infective  

  • Tanzania  

    Africa  

View report >

Opioid Market in Iran

  • December 2016
    8 pages
  • Opioid  

  • Iran  

View report >

Therapy and Hormone Market in South Korea

  • December 2016
    4 pages
  • Therapy  

    Hormone  

    Cancer  

  • South Korea  

View report >

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.